Wei Lun Chiang mark this message invalid request
｜originally written by Wei Lun Chiang
不正確。強生/嬌生（Johnson & Johnson）疫苗在美國食品和藥物管理局02/26之會議資料中顯示，該疫苗對避免中/重症的保護力為66.9 %，避免整體感染（包含輕症）的保護力為66.9 %。保護力遜於輝瑞-BNT、莫德納等疫苗，但優勢為單劑即可，和保存條件友善（2-8℃）。
參考文獻：
1. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting. 2021/02/26. U.S. Food and Drug Administration.
參考文獻：
1. Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19. Vaccines and Related Biological Products Advisory Committee Meeting. 2021/02/26. U.S. Food and Drug Administration.
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.